Location: Home
  • search
  • go
  • Relate News
  • 3/24/2021Hainan's Lecheng Pilot Zone Launches Insurance to Cover Innovative New...
  • 3/24/2021Ping An and Zhongshan Hospital Join Hands for Healthcare+Technology+Fi...
  • 3/23/2021Takeda Unveils Open Incubation Platform as Part of Its Digital Strateg...
  • 3/23/2021Regencell Bioscience Files for An $18M US IPO
  • 3/23/2021China Introduces New Program for Early Access to New Drugs in the Grea...
  • 3/23/2021Eucure Announces Breakthu Phase I Results for Anti-CTLA-4 in Combo wit...
  • 3/23/2021Citrine Granted Clinical Trial Waiver for Narcolepsy Drug Wakix and ...
  • 3/23/2021EpimAb Raises $120M Pre-IPO with Global Expansion Aspirations
  • 3/23/2021Everest Med Files NDA for cIAI Drug Xerava (Eravacycline) in China
  • 3/23/2021NMPA Revises Packages Insert of Systemic Quinolone Drugs
  • 3/23/2021NMPA Revises Packages Insert of Mouse Nerve Growth Factor
  • 3/23/2021NIFDC Issues the 2020 National Drug Sample Inspection Annual Report
  • 3/23/2021Review of Chinese CDE-Accepted Drug Registration Applications in 2020
  • 3/22/2021Bayer Launches Prostate Cancer Drugs Nubeqa and Xofigo in China
  • 3/22/2021Sesen and Qilu Announce Chinese IND Approval for Vicineum
  • 3/19/2021Recent Executive Moves
  • 3/18/2021111, Inc. Enters Unique Strategic Partnership with BeiGene
  • 3/18/2021WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC...
  • 3/18/2021Complix Agrees with I-Mab to Develop Cell Penetrating Alphabodies aga...
  • 3/18/2021SAMR Issues the Measures on Supervision and Administration of Online T...
  • 3/18/2021NMPA Revises Packages Inserts of Haloperidol Formulations
  • 3/18/2021NMPA Revises Packages Inserts of Sodium Ferulate for Injection
  • 3/18/2021Ping An Good Doctor: Cross-Sectional Survey
  • 3/17/2021Pfizer To Be Granted Priority Review for Its NDA of Abrocitinib
  • 3/17/2021NHSA Releases Its 2020 Healthcare Security Sector Development Statisti...
  • 3/17/2021Daewoong Pharma Signs $338M Deal Licensing Out Fexuprazan to Yangtze ...
  • 3/16/2021AVEO Reclaims Full Global Rights to Antibody Drug from CANbridge
  • 3/16/2021CDE Issues the Technical Requirements for Topical Dermatological Gener...
  • 3/16/2021NHC Solicits Comments on the draft Provisions for Ethical Review of Li...
  • 3/16/2021Snapshot of 11 Domestic Class 1 New Drugs Approved in China Last Year
  • Page:195/775 Total number of articles:23243: [First][<<] [193] [194] [195] [196] [197] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group